title: Clinical and pathological analysis of transplant glomerulopathy cases.
abstract: Transplant glomerulopathy (TG) is involved in the criteria of chronic active antibody-mediated rejection (c-AMR) in Banff '09 classification.
  
  
  METHODS
  TG was diagnosed in 58 renal allograft biopsy specimens (BS) from 37 renal transplant patients.
  
  
  RESULTS
  Among 58 BS of TG, 27 BS were mild (cg1), 16 were moderate (cg2), and 15 were severe (cg3). Peritubular capillaritis was present in 49 (84%), transplant glomerulitis was seen in 47 BS (81%), interstitial fibrosis and tubular atrophy in 47 (81%) and the thickening of the peritubular capillary (PTC) basement membrane (PTCBM) in 44 (76%), and interstitial inflammation was present in 26 BS (45%). C4d deposition in PTC was presented in 32 BS (55%). The circulating anti-HLA alloantibody was detected in 38 times (76%), of which 27/38 (54%) were donor-specific antibodies. Deterioration of renal allografts' function after biopsies was seen in 12 patients (32%) with six of them lost their graft.
  
  
  CONCLUSIONS
  We suggest that histopathological changes of TG accompanying by transplant glomerulitis, peritubular capillaritis, the thickening of the PTCBM, and circulating anti-HLA antibodies might indicate c-AMR, even if C4d deposition in PTC is negative. The prognosis of the graft exhibiting TG was relatively good under the present immunosuppression protocol in short time.
authors: Department of Urology, Tokyo Women's Medical University, Tokyo, Japan. Houichi@aol.com
authors: Tomokazu
authors: T
authors: Shimizu
authors: Tatsu
authors: T
authors: Tanabe
authors: Hiroki
authors: H
authors: Shirakawa
authors: Kazuya
authors: K
authors: Omoto
authors: Hideki
authors: H
authors: Ishida
authors: Kazunari
authors: K
authors: Tanabe
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015935:Complement C4b / Q000276:immunology; D005260:Female; D015433:Glomerulonephritis, Membranous / Q000150:complications / Q000401:mortality / Q000473:pathology*; D006084:Graft Rejection / Q000209:etiology / Q000401:mortality / Q000473:pathology*; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000276:immunology; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D014184:Transplantation, Homologous; D055815:Young Adult
chemical_list: D010446:Peptide Fragments; D015935:Complement C4b; C032261:complement C4d